You just read:

CASI Pharmaceuticals Announces Poster Presentation At The 2017 San Antonio Breast Cancer SymposiumTM (SABCS) On ENMD-2076 In Patients With Triple-Negative Breast Cancer (TNBC)

News provided by

CASI Pharmaceuticals, Inc.

Dec 01, 2017, 06:00 EST